Opsy Holding AbNGM: OPSYH

OPSYH: Opsy acquisition marks a decisive shift from biotech to insuretech SaaS focus

· Issued by Opsy Holding Ab

Foxy-5 failed in phase 2, prompting a strategic pivot to acquire Opsy AB, an insuretech firm, via a reverse takeover. The deal, if approved, shifts focus to SaaS for insurance claims; otherwise, liquidation is likely.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Opsy Holding Ab

All Opsy Holding Ab news releases